Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fuji
Federal Trade Commission
US Department of Justice
Johnson and Johnson
McKesson

Generated: June 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CANGRELOR

« Back to Dashboard

Clinical Trials for Cangrelor

Trial ID Title Status Sponsor Phase Summary
NCT00102674 Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor Completed The Medicines Company Phase 1 The purposes of this study are to: - Evaluate the tolerability of two cangrelor regimens. - Compare the PD of cangrelor regimens with oral clopidogrel.
NCT00305162 A Clinical Trial to Demonstrate the Efficacy of Cangrelor Terminated The Medicines Company Phase 3 The primary objective of this study is to demonstrate that the efficacy of cangrelor is superior, or at least non-inferior, to that of clopidogrel in subjects requiring PCI.
NCT00385138 Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. Terminated The Medicines Company Phase 3 The primary objective of this study is to demonstrate that the efficacy of cangrelor (combined with usual care) is superior to that of usual care, in subjects requiring percutaneous coronary intervention (PCI) as measured by a composite of all-cause mortality, myocardial infarction (MI), and ischemia-driven revascularization (IDR).
Trial ID Title Status Sponsor Phase Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Cangrelor

Condition Name

Condition Name for Cangrelor
Intervention Trials
Coronary Artery Disease 5
STEMI - ST Elevation Myocardial Infarction 3
Acute Coronary Syndrome (ACS) 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Cangrelor
Intervention Trials
Myocardial Infarction 8
Acute Coronary Syndrome 7
Infarction 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cangrelor

Trials by Country

Trials by Country for Cangrelor
Location Trials
United States 13
Czechia 2
Italy 1
Denmark 1
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Cangrelor
Location Trials
Vermont 3
Kentucky 2
Florida 2
Pennsylvania 1
South Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cangrelor

Clinical Trial Phase

Clinical Trial Phase for Cangrelor
Clinical Trial Phase Trials
Phase 4 7
Phase 3 3
Phase 2 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Cangrelor
Clinical Trial Phase Trials
Completed 9
Not yet recruiting 7
Recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cangrelor

Sponsor Name

Sponsor Name for Cangrelor
Sponsor Trials
The Medicines Company 11
University of Florida 2
University of Aarhus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Cangrelor
Sponsor Trials
Other 18
Industry 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Farmers Insurance
US Department of Justice
UBS
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.